These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1086 related articles for article (PubMed ID: 33141657)
1. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657 [TBL] [Abstract][Full Text] [Related]
2. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892 [TBL] [Abstract][Full Text] [Related]
4. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782 [TBL] [Abstract][Full Text] [Related]
5. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099 [TBL] [Abstract][Full Text] [Related]
6. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501 [TBL] [Abstract][Full Text] [Related]
8. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Moss SM; Cuckle H; Evans A; Johns L; Waller M; Bobrow L; Lancet; 2006 Dec; 368(9552):2053-60. PubMed ID: 17161727 [TBL] [Abstract][Full Text] [Related]
9. Mammography screening: A major issue in medicine. Autier P; Boniol M Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783 [TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
11. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial. Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459 [TBL] [Abstract][Full Text] [Related]
12. Responding to the challenges of breast cancer in egypt and other arab countries. El Saghir NS J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588 [TBL] [Abstract][Full Text] [Related]
13. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642 [TBL] [Abstract][Full Text] [Related]
14. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme--a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone. Gilbert FJ; Tucker L; Gillan MG; Willsher P; Cooke J; Duncan KA; Michell MJ; Dobson HM; Lim YY; Purushothaman H; Strudley C; Astley SM; Morrish O; Young KC; Duffy SW Health Technol Assess; 2015 Jan; 19(4):i-xxv, 1-136. PubMed ID: 25599513 [TBL] [Abstract][Full Text] [Related]
15. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT. Ashburn A; Pickering R; McIntosh E; Hulbert S; Rochester L; Roberts HC; Nieuwboer A; Kunkel D; Goodwin VA; Lamb SE; Ballinger C; Seymour KC Health Technol Assess; 2019 Jul; 23(36):1-150. PubMed ID: 31339100 [TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years. Moss S; Thomas I; Evans A; Thomas B; Johns L; Br J Cancer; 2005 Mar; 92(5):949-54. PubMed ID: 15726102 [TBL] [Abstract][Full Text] [Related]